DXCM
Dexcom Inc
MEDICAL DEVICES · HEALTHCARE
DexCom, Inc. is a prominent leader in diabetes management, renowned for its state-of-the-art continuous glucose monitoring (CGM) systems that empower patients to optimize their glucose levels effectively. Based in San Diego, California, with a manufacturing facility in Mesa, Arizona, the company is ...
$73.78
+0.48% (+$0.35)
Volume
3.70M
52W High
$89.98
52W Low
$54.11
Market Cap
$26.73B
What to Watch This Quarter
Based on historical dataConsensus EPS
$0.47
Whisper EPS
$0.49
4.3% above consensus
Last Quarter
$0.68
Current Streak
4 Beats
Avg Surprise (4Q)
+6.47%
Next Earnings Report
Reports in 49 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q4 2025
Feb 12, 2026
1-Day:
+7.59%
5-Day:
+8.22%
Q4 2025
Feb 5, 2026
1-Day:
+0.11%
5-Day:
-2.48%
Q3 2025
Oct 30, 2025
1-Day:
-14.63%
5-Day:
-10.29%
Q2 2025
Jul 30, 2025
1-Day:
-9.31%
5-Day:
-14.38%
Revenue & Financial Performance
Revenue Whisper
$1.28B
TWN Proprietary Estimate
Last Quarter Revenue
$1.26B
+13.1% YoY
Gross Margin
62.9%
Net Margin: 21.2%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $1.26B | +13.1% | 62.9% | 25.6% | $267.3M |
| Q3'25 | $1.21B | +21.6% | 60.5% | 20.1% | $283.8M |
| Q2'25 | $1.16B | +15.2% | 59.5% | 18.4% | $179.8M |
| Q1'25 | $1.04B | +12.5% | 56.9% | 12.9% | $105.4M |
| Q4'24 | $1.11B | +7.6% | 58.9% | 17.0% | $151.7M |
| Q3'24 | $994.2M | +2.0% | 59.7% | 15.3% | $134.6M |
| Q2'24 | $1.00B | +15.3% | 62.4% | 15.7% | $143.5M |
| Q1'24 | $921.0M | +24.2% | 61.0% | 11.0% | $146.4M |
Company Information
Symbol
DXCM
Company
Dexcom Inc
Market Cap
$26.73B
Sector
HEALTHCARE
Next Earnings
Apr 23, 2026
Also Reporting Soon
Companies reporting earnings around the same time as DXCM
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in MEDICAL DEVICES
Compare DXCM with competitors
Side-by-side earnings comparison